Enclomiphene vs TRT: which should I consider first?

Short answer

• If you want to preserve or restore fertility (or are trying to avoid testicular shrinkage), start with a drug that stimulates your own testosterone production — a SERM or hCG — before considered lifelong testosterone replacement therapy (TRT).
• If you have primary testicular failure (high LH), or very low testosterone with severe symptoms and no desire for future fertility, TRT is usually the appropriate first choice.

Why (mechanisms & implications)

• Enclomiphene / clomiphene (SERMs): act at the hypothalamus/pituitary to raise LH/FSH and thereby increase your own testicular testosterone production. That preserves or often increases sperm production and testicular size. Good for secondary hypogonadism (low T with low/normal LH) and men who want children.
• TRT (injectable, gel, patch): supplies exogenous testosterone and reliably improves symptoms (energy, libido, mood, muscle). But TRT suppresses LH/FSH and usually reduces sperm production and causes testicular atrophy, so it harms fertility unless combined with hCG.

Which clinical features point to one vs the other

• Consider SERM/hCG first if:
  • You want to father children or maintain fertility
  • Your labs show low T with low/normal LH (secondary hypogonadism)
  • Testes are normal in size and you tolerate oral therapy
• Consider TRT first if:
  • You have primary hypogonadism (low T with high LH) — testes can’t respond to LH stimulation
  • You have very low T with significant symptoms and are not interested in fertility
  • You want the most predictable symptomatic relief

Practical notes, availability & examples

• Enclomiphene (brand: Androxal) was studied for male hypogonadism but is not widely available in routine clinical practice in many places. Because of that, many physicians use clomiphene citrate (brand names Clomid, Serophene) off‑label in men — it works similarly for raising endogenous T and is widely accessible and inexpensive.
• TRT options (brands/examples): injectable testosterone cypionate or enanthate (generic Depo‑Testosterone or pharmacy generics) — common and inexpensive; topical gels like AndroGel (AbbVie) or Testim — convenient but transfer risk to others; patches like Androderm — steady dosing but skin irritation in some men.
• If you need to be on TRT but want to preserve fertility, clinicians often add hCG (brands: Pregnyl, Novarel, recombinant Ovidrel) or use selective protocols with SERMs.

Risks and monitoring

• SERMs (clomiphene/enclomiphene): possible mood changes, visual disturbance (rare), and increased clotting risk in susceptible people. Monitor testosterone, LH/FSH, and occasionally liver tests and symptoms.
• TRT: can cause erythrocytosis (monitor CBC), acne, sleep apnea worsening, testicular atrophy, and decreased sperm count; potential prostate‑related issues so monitor PSA and do periodic exams. Baseline labs before any therapy: morning total testosterone (repeat), LH, FSH, prolactin (if LH low), CBC, PSA (age-appropriate), and metabolic/cardiovascular assessment.
• Thresholds: symptomatic men with total testosterone consistently below ~300 ng/dL (morning, repeated) are commonly considered for treatment, but decisions must be individualized.

Recommendation for next steps

1. Get proper baseline testing (morning total T repeated, LH, FSH, prolactin, CBC, PSA as age-appropriate).
2. See an endocrinologist or reproductive urologist to interpret whether your hypogonadism is primary vs secondary and discuss fertility plans.
3. If fertility matters or LH is low/normal → discuss clomiphene/enclomiphene (or hCG) first. If primary hypogonadism or no fertility desire → discuss TRT (injectable or gel) as a first-line option.
4. If cost/availability is a concern: clomiphene (Clomid) is a practical, commonly used alternative to enclomiphene; for TRT, generic testosterone cypionate injections are inexpensive and effective.

If you want, tell me:

• Your latest morning total testosterone, LH/FSH, and whether you want children — I can give a more specific suggestion and list likely monitoring steps.